简介：教育能够改变个人的生活,促进社会的变革。儿童在学校学习成绩的好坏,与他们的健康水平,包括视觉健康之间有着密切的联系。这反过来又影响到儿童未来的生活质量与经济生产力。学校的眼睛健康项目给上学儿童们提供了一个独一无二的机会,使他们能拥有全面的眼睛健康服务。

简介：青光眼是全球第二大致盲性眼病，全球有近4亿青光眼患者，我国青光眼的患病率约为1.3%，居世界第二位，约有2300万青光眼患者。临床上青光眼导致的失明占整个眼科致盲的25%-40%，是世界上第一位不可逆性致盲性眼病。目前为止，人类尚无一种有效治疗手段能够治愈这一疾病。患者一旦出现视力下降、视物模糊、眼红眼痛等症状就需要及时就医，青光眼对视力的损害是不可逆转的，最终可能导致失明。青光眼的病理基础是眼压升高，眼压的调节功能会受到影响，视物模糊会使患者以为自己只是看花眼了。患者往往通过眼部不适症状判断自己是否患有青光眼，这是一种非常主观的判断方法。那么青光眼有哪些症状呢？

简介：AIM:Tofindouttheoutcomeoflaserphotocoagulationinclinicallysignificantmacularedema(CSME)byopticalcoherencetomography(OCT).·METHODS:Itwasaprospective,non-controlled,caseseriesstudyenrolling81eyesof64patientswithCSMEbetweenAugust2008andJanuary2010.AllpatientsreceivedmodifiedgridphotocoagulationwithfrequencydoubledNd:YAGlaser.Eachpatientwasevaluatedintermsofbest-correctedvisualacuity(BCVA)andregressionorprogressionofmaculopathyafterlasertherapyat1,3and6months.Spearman’scorrelationtestwasusedtoshowthecorrelationbetweenBCVAandtotalmacularvolume(TMV).Analysisofvariance(ANOVA)wasusedtocompareamonggroupsandindependentt-testwasusedtocompareineachgroup.·RESULTS:ThereishighcorrelationbetweenBCVAandTMV(P≤0.001).BCVAimprovedin50.6%,remainedstaticin39.5%anddeterioratedin9.9%patientsafter6monthoftreatment.TheBaselineTMV(meanandSD)were9.26±1.83,10.4±2.38,11.5±3.05,8.89±0.75and9.47±1.98mm3fordifferentOCTpatterns,ST(spongelikethickening),CMO(cystoidmacularedema),SFD(subfovealdetachment),VMIA(Vitreomacularinterfaceabnormality)andaverageTMVrespectively(P=0.04).After6monthsoflasertreatment,themeanTMVdecreasedfrom9.47±1.98mm3to8.77±1.31mm3(P=0.01).InSTtherewassignificantdecreaseinTMV,P=0.01,Furtherwithinthesegroupsat6months,theyweresignificantlydifferent,P=0.01.·CONCLUSION:OCTshowedthedifferentmorphologicalvariantofCSMEwhiletheresponseoftreatmentisdifferent.TMVdecreasedthemostandhenceshowedtheimprovementinvisionafter6monthsoflasertreatment.IntheeraofAntivascularendothelialgrowthfactors(VEGFs),efficacyoflaserseemstobeinshadowbutitisstillfirstlineoftreatmentindevelopingnationlikeNepalwhereantiVEGFsmaynotbeeasilyavailableandaffordable.